RE:RE:RE:RE:RE:RE:Q3 ResultsExtremely positive.
Everything is now in place for sales to increase exponentially.
The large impact Medline deal kicks in this quarter and should progressively boost sales by $50 million per year or more.
$11 million in new ME contracts kick in during the coming quarter.
As well,the large impact Latin American deal with 9 countries also kicks in during the coming quarter and negotiations are underway to add another 8 LA countries.
The new office in China has been working hard to consolidate joint arrangements with Chinese companies in this space and we should see the first deal in the months to come.
And new products are nearing approval for release.
Covalon is currently trading below its peer multiple and offers quick upside as new deals/ revenue gains become realized over the coming months..